thumbnail image
ABOUT US
REFERENCE CENTERTECHNOLOGYFUJIFILM's HISTORYVETERINARY
ABOUT US
REFERENCE CENTERTECHNOLOGYFUJIFILM's HISTORYVETERINARY
  • ABOUT US
    REFERENCE CENTERTECHNOLOGYFUJIFILM's HISTORYVETERINARY
    ABOUT US
    REFERENCE CENTERTECHNOLOGYFUJIFILM's HISTORYVETERINARY
    ABOUT US
    REFERENCE CENTERTECHNOLOGYFUJIFILM's HISTORYVETERINARY
    • ABOUT US
    • CHALLENGE & SOLUTION
      • DRY CLINICAL CHEMISTRY
      • RAPID DIAGNOSTICS SYSTEM
      • FECAL IMMUNOCHEMICAL TEST
    • REFERENCE CENTER
    • TECHNOLOGY
    • FUJIFILM's HISTORY
    • VETERINARY
    • Search
      • TRANSFORMING

        FROM

        PHOTO FILM

        TO

        HEALTHCARE

      • FACT SHEET

        FUJIFILM Holdings Corporation has 283 consolidated subsidiaries worldwide – with 77,739 employees – who all contribute to the output of this dynamic organization, working tirelessly to improve the quality of our collective lives.

        ESTABLISHED IN

        1934

        COMPANIES WORLDWIDE

        283

        EMPLOYEES WORLDWIDE

        77,739

        GLOBAL REVENUE (as of Mar, 2018)

        $23 billion

        GLOBAL HEALTHCARE REVENUE

        $4.2 billion

      • MILESTONE AND ACHIEVEMENTS

        With its wide range of technologies and expansive vision, Fujifilm leverages the products, services, and hard-earned expertise that is rooted in the development of photographic products to enhance the quality of life of people worldwide.

        1934

        FOUNDATION OF THE COMPANY

        The company (Fuji Photo Film Co., Ltd.) was established in1934 with the aim of being the first Japanese producer of photographic films

        1936

        First steps in Healthcare with X-ray film

        Our first steps in the development of X-ray film in 1936, and later advances in imaging film and archiving film set the course for a long line of breakthrough technologies.

        1984

        First steps in IVD with Dri-Chem (Dry Clinical Chemistry)

        Our first steps in the development of Dry Clinical Chemistry analyzer in 1984, and later advances in imaging film and archiving film set the course for a long line of breakthrough technologies.

        1993-2007

        Expanding Dri-Chem Series (Dry Clinical Chemistry)

        Following our first Dry Clinical Chemistry analyzer; Dri-Chem 1000, we have been evolving the dry chemistry technology and released multiple Dri-Chem analyzers.

        2011-2013

        Launching the first Immunological POC system

        Our first steps in the development of POC Immunological test in 2011. Immuno AG1 for the early detection of Influenza Virus, and Immuno AU10V(*) as the first in-house POC analyzer for TSH measurement for Veterinarians. (*) Immuno AU10V: for Veterinary use only.

        2012-2017

        Next generation Dri-Chem: NX700, NX500, NX10

        While retaining the characteristics of Dri-Chem series, NX series provides one rank higher usability. NX series can be operated intuitively so that all types of healthcare providers can use it for their patient care. Click images to see details.

        2017

        Acquisition of WAKO PURECHEMICAL

        In 2017, Fujifilm acquired a Japanese leading reagent manufacturer Wako Pure Chemical Industries, Ltd. to generate the substantial synergies in the area of regenerative medicine, in-vitro diagnosis (IVD) and pharmaceutical CDMO. The acquisition of Wako will be a key milestone for Fujifilm's future business growth.

        2018

        Next Generation RAPID DIAGNOSTICS SYSTEM: IMMUNO AG2

        With IMMUNO AG2 we have realized the easier and intuitive operation while retaining the unique features of IMMUNO AG1 which had been selected by more than 14,000 healthcare provides WW.

        Click images to see details.

        2019

        First steps in FECAL IMMUNOCHEMICAL TEST (FIT)

        Our first steps in fighting against Colorectal cancer which is #2 common cause of cancer related death in Europe (#2 common cancer in Women after Breast Cancer, and #3 most common cancer in Men after lung and prostate Cancer). Click images to see details.

        And the future...

        Our commitment: continue to invest for IVD

        As one of Fujifilm's strategic fields, our commitment is to continue to innovate and invest in In-Vitro Diagnostics field. Fujifilm is Never Stop to evolve ourselves to contribute to the people's quality of life.

      • FUJIFILM IVD STORY

        Our challenge started in 1984

         

        We had evolved the technology which we had been cultivating in “Photo field” to develop our unique “Dry Clinical Chemistry Solution”

         

        Our Commitment is to continue to invest in In-Vitro Diagnostics (IVD) field to contribute to the quality of life.

         

      •  

        Check all News, Videos and Brochure

         

        GO TO REFERENCE CENTER
      • CONTACT US

        Interested? Contact us for more information.

        FUJIFILM EUROPE
        HEESEN STR 31, DUSSELDORF, GERMANY
        nozomi.sekine@fujifilm.com
        Submit

      © 2021

      Privacy Policy     Terms & Conditions     Imprint

        Home
        Contact
      All Posts
      ×
      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More